All Stories

  1. A tumorigenesis threshold for endogenous Myc revealed by dosage-compensation for Myc haploinsufficiency in the absence of p53
  2. An Open-Source Normothermic Perfusion System Designed for Research Scientists
  3. Editor’s Note: mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
  4. Elevated tumor NOS2/COX2 promotes immunosuppressive phenotypes associated with poor survival in ER– breast cancer
  5. Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series
  6. Targeting the SARS-CoV-2 reservoir in long COVID
  7. Deconvolution of cell types and states in spatial multiomics utilizing TACIT
  8. Immunization with peptide encapsulated within synthetic spores activates T cell responses and reduces tumor growth
  9. DNA methylation patterns are influenced by Pax3::Foxo1 expression and developmental lineage in rhabdomyosarcoma tumours forming in genetically engineered mouse models
  10. SARS-CoV-2 infection of salivary glands compromises the production of a secreted antifungal peptide with potential implications for development of oral candidiasis
  11. Analysis of Glomerular Transcriptomes from Nephrotic Patients SuggestAPOL1Risk Variants Impact Parietal Epithelial Cells
  12. Single-Nucleus RNA Sequencing Reveals Loss of Distal Convoluted Tubule 1 Renal Tubules in HIV Viral Protein R Transgenic Mice
  13. Tumor NOS2 and COX2 Spatial Juxtaposition with CD8+ T Cells Promote Metastatic and Cancer Stem Cell Niches that Lead to Poor Outcome in ER− Breast Cancer
  14. A novel pathogenic germline chromosome 3 inversion in von Hippel-Lindau disease
  15. Maternal prolactin or estrogen signaling in hepatocytes does not regulate iron homeostasis during pregnancy
  16. Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium
  17. Contribution of Prediagnostic Host Factors to Shaping the Stromal Microenvironment of Breast Cancer among Sub-Saharan African Women
  18. Spatial Deconvolution of Cell Types and Cell States at Scale Utilizing TACIT
  19. Characterization of an expanded set of assays for immunomodulatory proteins using targeted mass spectrometry
  20. Spatial Deconvolution of Cell Types and Cell States at Scale Utilizing TACIT
  21. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
  22. Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors
  23. SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal Innate Immunity and Predisposes to Oral Candidiasis
  24. Single-Cell Transcriptional Signatures of Glomerular Disease in Transgenic Mice with APOL1 Variants
  25. Growth in children with nephrotic syndrome: a post hoc analysis of the NEPTUNE study
  26. ATOH1, TFAP2B, and CEACAM6 as Immunohistochemical Markers to Distinguish Merkel Cell Carcinoma and Small Cell Lung Cancer
  27. Microenvironment Shapes Small Cell Lung Cancer Neuroendocrine States and Presents Therapeutic Opportunities
  28. Longitudinal analysis of blood pressure and lipids in childhood nephrotic syndrome
  29. Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today
  30. Pediatric contributions and lessons learned from the NEPTUNE cohort study
  31. Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer
  32. NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER-Breast Cancer
  33. Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients
  34. Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies
  35. Quality Assessment of Proteins and RNA Following Storage in Archival Formalin-Fixed Paraffin-Embedded Human Breast Cancer Tissue Microarray Sections
  36. Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma
  37. Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
  38. Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer
  39. Pulmonary Co-Infections Detected Premortem Underestimate Postmortem Findings in a COVID-19 Autopsy Case Series
  40. Clinical and biological heterogeneity of multisystem inflammatory syndrome in adults following SARS-CoV-2 infection: a case series
  41. Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
  42. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome
  43. A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
  44. Associations of breast cancer etiologic factors with stromal microenvironment of primary invasive breast cancers in the Ghana Breast Health Study
  45. The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer
  46. Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER-Breast Tumors that Lead to Poor Outcome
  47. APOL1 kidney risk variants in glomerular diseases modeled in transgenic mice
  48. Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome
  49. Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling
  50. HIV viral protein R induces loss of DCT1-type renal tubules
  51. Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  52. The Application of Guanidinium to Improve Biomolecule Quality in Fixed, Paraffin-embedded Tissue
  53. Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
  54. Cell-specific cargo delivery using synthetic bacterial spores
  55. Successful lung transplantation using an allograft from a COVID-19–recovered donor: a potential role for subgenomic RNA to guide organ utilization
  56. Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs
  57. SARS-CoV-2 infection and persistence in the human body and brain at autopsy
  58. Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer
  59. Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
  60. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
  61. The role of FXR and TGR5 in reversing and preventing progression of Western diet–induced hepatic steatosis, inflammation, and fibrosis in mice
  62. Variant APOL1 protein in plasma associates with larger particles in humans and mouse models of kidney injury
  63. Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome
  64. HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule
  65. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19
  66. Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function LHCGR Variant
  67. Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race
  68. Reproducible, high-dimensional imaging in archival human tissue by multiplexed ion beam imaging by time-of-flight (MIBI-TOF)
  69. A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis
  70. NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+T Cell Spatial Orientation and Density
  71. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
  72. Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis
  73. Locoregional tumor burden and risk of mortality in metastatic breast cancer
  74. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19
  75. Single‐cell biology uncovers apoptotic cell death and its spatial organization as a potential modifier of tumor diversity in HCC
  76. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1
  77. NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8 T Cell Spatial Orientation and Density
  78. Advancing Research on Medical Image Perception by Strengthening Multidisciplinary Collaboration
  79. Mitochondrial C5aR1 activity in macrophages controls IL-1β production underlying sterile inflammation
  80. SARS-CoV-2 infection and persistence throughout the human body and brain
  81. Evidence of SARS-CoV-2-Specific T-Cell-Mediated Myocarditis in a MIS-A Case
  82. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
  83. Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging
  84. Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens
  85. Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy
  86. Reproducible, high-dimensional imaging in archival human tissue by Multiplexed Ion Beam Imaging by Time-of-Flight (MIBI-TOF)
  87. Detailed Quantification of Glomerular Structural Lesions Associates with Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome
  88. Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
  89. Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition
  90. Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network
  91. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
  92. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
  93. IGF-1 Receptor Signaling Regulates Type II Pneumocyte Senescence and Resulting Macrophage Polarization in Lung Fibrosis
  94. Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network
  95. Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer
  96. Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression
  97. Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature
  98. SARS-CoV-2 infection of the oral cavity and saliva
  99. Intratumoral γδ T‐Cell Infiltrates, Chemokine (C‐C Motif) Ligand 4/Chemokine (C‐C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma
  100. A glomerular transcriptomic landscape of APOL1 in Black patients with focal segmental glomerulosclerosis
  101. INFORM: INFrared-based ORganizational Measurements of tumor and its microenvironment to predict patient survival
  102. Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7
  103. Kaiso (ZBTB33) subcellular partitioning functionally links LC3A/B, the tumor microenvironment, and breast cancer survival
  104. MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors
  105. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
  106. CRY1Regulates Chemoresistance in Association WithNANOGby Inhibiting Apoptosisvia STAT3Pathway in Patients With Cervical Cancer
  107. Development and evaluation of deep learning–based segmentation of histologic structures in the kidney cortex with multiple histologic stains
  108. Author Correction: PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
  109. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
  110. Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis
  111. Prognostic implication of SOX2 expression in small intestinal adenocarcinoma
  112. In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  113. Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair–deficient tumors
  114. The Use of Quantitative Digital Pathology to Measure Proteoglycan and Glycosaminoglycan Expression and Accumulation in Healthy and Diseased Tissues
  115. Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast
  116. 4-HNE Immunohistochemistry and Image Analysis for Detection of Lipid Peroxidation in Human Liver Samples Using Vitamin E Treatment in NAFLD as a Proof of Concept
  117. Digital pathology and computational image analysis in nephropathology
  118. Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients
  119. LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
  120. Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer
  121. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice
  122. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
  123. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
  124. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
  125. Low Epstein–Barr Virus Prevalence in Cardia Gastric Cancer Among a High-Incidence Chinese Population
  126. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer
  127. Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis
  128. Racial Differences in the Association Between Luminal Master Regulator Gene Expression Levels and Breast Cancer Survival
  129. The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice
  130. Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
  131. Nephrotic Syndrome Disease Activity Predicts Severity of the Associated Hypercoagulopathy
  132. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population‐based case–control study
  133. The Challenges of Optimizing Biomarkers to Guide Clinical Decision Making
  134. Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes
  135. Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes
  136. HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
  137. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis
  138. CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
  139. Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy
  140. Reproductive Factors and Risk of Breast Cancer by Tumor Subtypes among Ghanaian Women: A Population-based Case-control Study
  141. Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density
  142. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma
  143. T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
  144. Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy
  145. ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
  146. Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
  147. Enlightening kidney pathophysiology
  148. Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein
  149. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer
  150. No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication
  151. A dataset describing a suite of novel antibody reagents for the RAS signaling network
  152. The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network
  153. Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
  154. A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN
  155. Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer
  156. Plasma Zonulin Levels in Childhood Nephrotic Syndrome
  157. A mouse model of Proteus syndrome
  158. Health-related quality of life in glomerular disease
  159. Hepatitis B Surface Antigen Activates Unfolded Protein Response in Forming Ground Glass Hepatocytes of Chronic Hepatitis B
  160. Data, Information, and Knowledge
  161. An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers
  162. Scale embedding shared neural networks for multiscale histological analysis of prostate cancer
  163. Combination Immunotherapy with IL-4 Pseudomonas Exotoxin and IFN-α and IFN-γ Mediate Antitumor Effects in vitro and in a Mouse Model of Human Ovarian Cancer
  164. APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
  165. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC)
  166. Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells
  167. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
  168. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion‐positive and fusion‐negative rhabdomyosarcoma
  169. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma
  170. Agreement in Histological Assessment of Mitotic Activity Between Microscopy and Digital Whole Slide Images Informs Conversion for Clinical Diagnosis
  171. Automated Computational Detection, Quantitation, and Mapping of Mitosis in Whole-Slide Images for Clinically Actionable Surgical Pathology Decision Support
  172. Reproductive Factors and Risk of Breast Cancer by Tumour Subtypes Among Ghanaian Women: A Population-Based Case-Control Study
  173. Correction: Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF
  174. Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co‐immunostain: a retrospective study on reproducibility and clinical/prognostic correlates
  175. Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk MYCN-Not-Amplified Human Neuroblastoma
  176. APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R
  177. Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma
  178. A transatlantic perspective on the integration of immuno-oncology prognostic and predictive biomarkers in innovative clinical trial design
  179. Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning
  180. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance
  181. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
  182. Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer
  183. A multiprotein supercomplex controlling oncogenic signalling in lymphoma
  184. Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3–NANOG Axis
  185. E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
  186. Integrated proteogenomic analysis of metastatic thoracic tumors identifies APOBEC mutagenesis and copy number alterations as drivers of proteogenomic tumor evolution and heterogeneity
  187. Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors
  188. Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation
  189. RE: Elevated Bladder Cancer in Northern New England: The Role of Drinking Water and Arsenic
  190. Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
  191. Reproducibility and Feasibility of Strategies for Morphologic Assessment of Renal Biopsies Using the Nephrotic Syndrome Study Network Digital Pathology Scoring System
  192. The Role of Extracellular Matrix in Innate Immunity, Fugues of Evolution
  193. APOBEC Mutagenesis and Copy Number Alterations are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors
  194. Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
  195. Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives
  196. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors
  197. Societal challenges of precision medicine: Bringing order to chaos
  198. Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on ...
  199. Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer
  200. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors
  201. The anti-cancer effects of itraconazole in epithelial ovarian cancer
  202. Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
  203. Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer
  204. HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells
  205. Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
  206. The Impact Factor Is a 20th-Century Relic in an Electronic Journal World of Instant Citation Counts
  207. Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis
  208. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer
  209. Multiview boosting digital pathology analysis of prostate cancer
  210. Formulation and pH of the Buffered Ethanol Fixative BE70
  211. Editor’s Note
  212. Computational analysis of the mesenchymal signature landscape in gliomas
  213. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
  214. Lumen-based detection of prostate cancer via convolutional neural networks
  215. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma
  216. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies
  217. Digital pathology imaging as a novel platform for standardization and globalization of quantitative nephropathology
  218. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients
  219. API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
  220. Nuclear Architecture Analysis of Prostate Cancer via Convolutional Neural Networks
  221. Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa
  222. Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast
  223. Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF
  224. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer
  225. Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups
  226. Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis
  227. A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue
  228. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study
  229. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer
  230. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications
  231. Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue
  232. The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies
  233. Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations
  234. Automated prostate tissue referencing for cancer detection and diagnosis
  235. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients
  236. Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy
  237. The paraffin-embedded RNA metric (PERM) for RNA isolated from formalin-fixed, paraffin-embedded tissue
  238. Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images
  239. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
  240. High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
  241. Reproducibility: It Is Just Good Science
  242. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease
  243. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
  244. Time Advances, People and Language Change, but the Fundamentals Remain the Same
  245. Baseline and early outcomes in glomerular disease patients
  246. Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities
  247. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
  248. Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas
  249. A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype
  250. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms
  251. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis
  252. Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling
  253. Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients
  254. Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
  255. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
  256. Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes
  257. Expression of Stanniocalcin 1 in Thyroid Side Population Cells and Thyroid Cancer Cells
  258. CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma
  259. Nucleus detection using gradient orientation information and linear least squares regression
  260. Uncertainty in the assessment of immunohistochemical staining with optical and digital microscopy: lessons from a reader study
  261. Risk of follicular lymphoma associated withBCL2translocations in peripheral blood
  262. Cross-Disciplinary Biomarkers Research: Lessons Learned by the CKD Biomarkers Consortium
  263. Cell-Cycle Protein Expression in a Population-Based Study of Ovarian and Endometrial Cancers
  264. The Evolution of Pre-analytic Factors in Anatomic Pathology
  265. Proteomic Expressional Profiling of a Paraffin-Embedded Tissue by Multiplex Tissue Immunoblotting
  266. Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer
  267. A Well-Based Reverse-Phase Protein Array of Formalin-Fixed Paraffin-Embedded Tissue
  268. Tissue Microarray
  269. Greater absolute risk for all subtypes of breast cancer in the US than Malaysia
  270. Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast
  271. Evaluation environment for digital and analog pathology: a platform for validation studies
  272. The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease
  273. Improving the State of the Science of Immunohistochemistry
  274. Controls for Immunohistochemistry
  275. Terminal Duct Lobular Unit Involution of the Normal Breast: Implications for Breast Cancer Etiology
  276. microRNA Alterations Driving Acute and Late Stages of Radiation-Induced Fibrosis in a Murine Skin Model
  277. Brightfield Proximity Ligation Assay Reveals Both Canonical and Mixed Transforming Growth Factor- /Bone Morphogenetic Protein Smad Signaling Complexes in Tissue Sections
  278. Consistency and Standardization of Color in Medical Imaging: a Consensus Report
  279. Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
  280. AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
  281. Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer
  282. PLCE1 mRNA and Protein Expression and Survival of Patients with Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma
  283. Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
  284. CLPTM1L Promotes Growth and Enhances Aneuploidy in Pancreatic Cancer Cells
  285. Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner
  286. eeDAP: An evaluation environment for digital and analog pathology
  287. Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer
  288. Multiplex Quantitative Measurement of mRNAs From Fixed Tissue Microarray Sections
  289. Observer Performance in the Use of Digital and Optical Microscopy for the Interpretation of Tissue-Based Biomarkers
  290. MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
  291. HER-2 assessment in formalin-fixed paraffin-embedded breast cancer tissue by well-based reverse phase protein array
  292. Assessment of vascular endothelial growth factor in formalin fixed, paraffin embedded colon cancer specimens by means of a well-based reverse phase protein array
  293. Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer
  294. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
  295. Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody
  296. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression
  297. CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up
  298. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma
  299. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
  300. Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
  301. Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis
  302. Synaptonemal complex protein 3 as a novel prognostic marker in early stage non–small cell lung cancer
  303. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach
  304. Quantitative analysis of TDLUs using adaptive morphological shape techniques
  305. Erratum: Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
  306. Follicular Lymphomas in Children and Young Adults
  307. Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody
  308. Digital Pathology Evaluation in the Multicenter Nephrotic Syndrome Study Network (NEPTUNE)
  309. Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth
  310. ORIGINAL ARTICLEExpression Analysis of p16, c-Myc, and mSin3A in Non-small Cell Lung Cancer by Computer Aided Scoring and Analysis (CASA)
  311. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D)
  312. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry
  313. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer
  314. Genetic Variant as a Selection Marker for Anti-Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer
  315. Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
  316. Nanog signaling in cancer promotes stem-like phenotype and immune evasion
  317. HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma
  318. A crypticBAP1splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma
  319. Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer
  320. What Measures Should Biobankers Employ to Prevent Possible Glitches in Storage Technology?
  321. Evaluation of Lymphangiogenic Factors, Vascular Endothelial Growth Factor D and E-Cadherin in Distinguishing Inflammatory From Locally Advanced Breast Cancer
  322. Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repository
  323. Cell-Cycle Control in Urothelial Carcinoma: Large-scale Tissue Array Analysis of Tumor Tissue from Maine and Vermont
  324. Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data
  325. Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation
  326. A pressure cooking-based DNA extraction from archival formalin-fixed, paraffin-embedded tissue
  327. Human CCR4+CCR6+Th17 Cells Suppress Autologous CD8+ T Cell Responses
  328. Automatic detection of melanoma progression by histological analysis of secondary sites
  329. Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development
  330. Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers for Directing Patient Therapy
  331. mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
  332. Analysis of Terminal Duct Lobular Unit (TDLU) Involution in Luminal A and Basal Breast Cancers
  333. Extremely High Tp53 Mutation Load in Esophageal Squamous Cell Carcinoma in Golestan Province, Iran
  334. The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer
  335. What Are the Most Oppressing Legal and Ethical Issues Facing Biorepositories and What Are Some Strategies to Address Them?
  336. The role of secreted frizzled-related protein 2 expression in prostate cancer
  337. 56. Chemical preservation of tissue: Methods and models
  338. Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer
  339. Tissue Microarrays as a Tool in the Discovery and Validation of Predictive Biomarkers
  340. Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue Microarray
  341. Wilms Tumor-1, Claudin-1 and Ezrin Are Useful Immunohistochemical Markers That Help to Distinguish Schwannoma from Fibroblastic Meningioma
  342. Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells
  343. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations
  344. CLSI Releases Updated Guideline for the Development of Immunohistochemical Assays
  345. Downregulation of Filamin A Interacting Protein 1-Like is Associated with Promoter Methylation and Induces an Invasive Phenotype in Ovarian Cancer
  346. Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms
  347. Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma
  348. Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
  349. An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers
  350. Factors Influencing the Degradation of Archival Formalin-Fixed Paraffin-Embedded Tissue Sections
  351. Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
  352. Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers
  353. Multimodal microscopy for automated histologic analysis of prostate cancer
  354. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma
  355. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility
  356. Modeling metastasis biology and therapy in real time in the mouse lung
  357. Modeling metastasis biology and therapy in real time in the mouse lung
  358. Multiple Endocrine Neoplasia Type 1 Deletion in Pancreatic α-Cells Leads to Development of Insulinomas in Mice
  359. Immunoguided Laser Assisted Microdissection Techniques for DNA Methylation Analysis of Archival Tissue Specimens
  360. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran
  361. Characterizations and validations of novel antibodies toward translational research
  362. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays
  363. Histo-proteomic profiling of formalin-fixed, paraffin-embedded tissue
  364. Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations
  365. Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies
  366. Microscopic resolution imaging and proteomics correlation at histogeographically identical location: point by point correlation between ex vivo tissue imaging with high field MRI and multiplex tissue immunoblotting for proteomics profiling
  367. Analysis of the expression of human tumor antigens in ovarian cancer tissues
  368. Global Genomic and Proteomic Analysis Identifies Biological Pathways Related to High-Risk Neuroblastoma
  369. Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non-Small Cell Lung Cancer
  370. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation
  371. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
  372. Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
  373. Cytokeratin Immunoexpression in Esophageal Squamous Cell Carcinoma of High-risk Population in Northeast India
  374. The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
  375. Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma
  376. Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer
  377. DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer
  378. Molecular profiling to identify molecular mechanism in esophageal cancer with familial clustering
  379. Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
  380. Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray
  381. Sperm-Derived SPANX-B Is a Clinically Relevant Tumor Antigen That Is Expressed in Human Tumors and Readily Recognized by Human CD4+ and CD8+ T Cells
  382. Recapitulation of Pancreatic Neuroendocrine Tumors in Human Multiple Endocrine Neoplasia Type I Syndrome via Pdx1-Directed Inactivation of Men1
  383. The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
  384. Transfer and Multiplex Immunoblotting of a Paraffin Embedded Tissue
  385. Tissue Microarrays as a Tool in the Discovery and Validation of Tumor Markers
  386. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression
  387. Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
  388. Tumor vasculature-targeted delivery of tumor necrosis factor-α*
  389. DNA Methylation Represses IFN- -Induced and Signal Transducer and Activator of Transcription 1-Mediated IFN Regulatory Factor 8 Activation in Colon Carcinoma Cells
  390. Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation
  391. The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC
  392. Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma
  393. H. pylori-Induced Apoptosis in Human Gastric Cancer Cells Mediated via the Release of Apoptosis-Inducing Factor from Mitochondria
  394. Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry
  395. Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials
  396. Validation of proteomic-based discovery with tissue microarrays
  397. A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue
  398. Functional Characterization of Filamin A Interacting Protein 1-Like, a Novel Candidate for Antivascular Cancer Therapy
  399. Pharmacodynamic Assessment of Histone Deacetylase Inhibitors: Infrared Vibrational Spectroscopic Imaging of Protein Acetylation
  400. Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker
  401. Factors in Tissue Handling and Processing That Impact RNA Obtained From Formalin-fixed, Paraffin-embedded Tissue
  402. Overexpression of CDC25B and LAMC2 mRNA and Protein in Esophageal Squamous Cell Carcinomas and Premalignant Lesions in Subjects from a High-Risk Population in China
  403. Automated evaluation of HER-2/neu immunohistochemical expression in breast cancer using digital microscopy
  404. Altered Cytoplasmic-to-Nuclear Ratio of Survivin Is a Prognostic Indicator in Breast Cancer
  405. Tissue microarray: A simple technology that has revolutionized research in pathology
  406. Frozen Protein Arrays
  407. Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation
  408. The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation
  409. Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study
  410. Transactivation of the EGFR by AP-1 Is Induced by Helicobacter pylori in Gastric Cancer
  411. Liver proteomics for therapeutic drug discovery: Inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure*
  412. Variation in breast cancer hormone receptor andHER2levels by etiologic factors: A population-based analysis
  413. Dissecting the Akt/Mammalian Target of Rapamycin Signaling Network: Emerging Results from the Head and Neck Cancer Tissue Array Initiative
  414. Tissue microarrays enabling high-throughput molecular pathology
  415. Layered Peptide Array for Multiplex Immunohistochemistry
  416. Recommendations for Improved Standardization of Immunohistochemistry
  417. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
  418. Expression of EIF3-p48/INT6, TID1 and Patched in cancer, a profiling of multiple tumor types and correlation of expression
  419. Expression of the cytoskeleton linker protein ezrin in human cancers
  420. Proteomic expression profiling of thyroid neoplasms
  421. Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study
  422. Desmoglein 3 as a prognostic factor in lung cancer
  423. Layered expression scanning: Multiplex molecular analysis of diverse life science platforms
  424. Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis
  425. Cell microarray platform for anticancer drug development
  426. Optimization of Recovery of RNA From Formalin-fixed, Paraffin-embedded Tissue
  427. Markers and Tissue Resources for Melanoma: Meeting Report
  428. Ezrin mediates growth and survival in Ewing’s sarcoma through the AKT/mTOR, but not the MAPK, signaling pathway
  429. Tissue microarrays as a platform for proteomic investigation
  430. Construction and Validation of Tissue Microarrays of Ductal Carcinoma In Situ and Terminal Duct Lobular Units Associated With Invasive Breast Carcinoma
  431. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure
  432. High throughput assessment of cells and tissues: Bayesian classification of spectral metrics from infrared vibrational spectroscopic imaging data
  433. A Multiplex Tissue Immunoblotting Assay for Proteomic Profiling: A Pilot Study of the Normal to Tumor Transition of Esophageal Squamous Cell Carcinoma
  434. Framework for Parsing, Visualizing and Scoring Tissue Microarray Images
  435. Intravenously administered vitamin C as cancer therapy: three cases
  436. Spectrum of activity and molecular correlates of response to phosphatidylinositol ether lipid analogues, novel lipid-based inhibitors of Akt
  437. Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: Acute renal failure is dependent on MyD88 but not renal cell apoptosis
  438. The Role of Interleukin 1 in Growth and Metastasis of Human Cancer Xenografts
  439. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
  440. Transfer and multiplex immunoblotting of a paraffin embedded tissue
  441. Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
  442. [20] The Application of Tissue Microarrays in the Validation of Microarray Results
  443. Automated Confocal Imaging and High-Content Screening for Cytomics
  444. Evaluation of Two Phosphorylation Sites Improves the Prognostic Significance of Akt Activation in Non-Small-Cell Lung Cancer Tumors
  445. Tissues from population-based cancer registries: a novel approach to increasing research potential
  446. Tissue microarrays: bridging the gap between research and the clinic
  447. Infrared spectroscopic imaging for histopathologic recognition
  448. Schedule-dependent Inhibition of Hypoxia-inducible Factor-1  Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts
  449. A Recurrent Chromosome Breakpoint in Breast Cancer at the NRG1/Neuregulin 1/Heregulin Gene
  450. Evaluation of Biologic End Points and Pharmacokinetics in Patients With Metastatic Breast Cancer After Treatment With Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
  451. High Throughput Fourier Transform Infrared Spectroscopic Imaging for Histopathology
  452. Modulation of Tumor-host Interactions, Angiogenesis, and Tumor Growth by Tissue Inhibitor of Metalloproteinase 2 via a Novel Mechanism
  453. Discovery of Protein Biomarkers for Renal Diseases
  454. Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer
  455. Sil overexpression in lung cancer characterizes tumors with increased mitotic activity
  456. Randomized, Double-Blind, Placebo-Controlled Phase IIB Trial of the Cyclooxygenase Inhibitor Ketorolac as an Oral Rinse in Oropharyngeal Leukoplakia
  457. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
  458. Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas
  459. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice
  460. Comparative Evaluation of Super High-Resolution CT Scan and Virtual Bronchoscopy for the Detection of Tracheobronchial Malignancies*
  461. Renal Tumors in the Birt-Hogg-Dubé Syndrome
  462. Post-analysis follow-up and validation of microarray experiments
  463. Frozen protein arrays: A new method for arraying and detecting recombinant and native tissue proteins
  464. Microarray Gene Expression Analysis of Murine Tumor Heterogeneity Defined by Dynamic Contrast-Enhanced MRI
  465. Erratum
  466. Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts
  467. Specimen Morcellation after Laparoscopic Radical Nephrectomy: Confirmation of Histologic Diagnosis Using Needle Biopsy
  468. Differential expression of the mismatch repair genehMSH2 in malignant prostate tissue is associated with cancer recurrence
  469. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
  470. Intramedullary Spinal Cord Metastasis from Renal Cell Carcinoma
  471. Birt-Hogg-Dubé Syndrome, a Genodermatosis Associated with Spontaneous Pneumothorax and Kidney Neoplasia, Maps to Chromosome 17p11.2
  472. INTRAOPERATIVE ULTRASOUND DURING RENAL PARENCHYMAL SPARING SURGERY FOR HEREDITARY RENAL CANCERS:: A 10-YEAR EXPERIENCE
  473. Molecular cytogenetic characterization of early and late renal cell carcinomas in Von Hippel-Lindau disease
  474. Endothelial Monocyte Activating Polypeptide II Induces Endothelial Cell Apoptosis and May Inhibit Tumor Angiogenesis
  475. The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound Healing
  476. Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology
  477. Differential Function of Wilms Tumor Gene WT1 Splice Isoforms in Transcriptional Regulation
  478. Transcriptional Silencer of the Wilms' Tumor Gene WT1 Contains an Alu Repeat
  479. Design, Construction, and Use of Tissue Microarrays